{"id":"https://openalex.org/W2016042652","doi":"https://doi.org/10.1016/j.bmcl.2009.07.058","title":"Novel N-substituted 4-hydrazino piperidine derivative as a dipeptidyl peptidase IV inhibitor","display_name":"Novel N-substituted 4-hydrazino piperidine derivative as a dipeptidyl peptidase IV inhibitor","publication_year":2009,"publication_date":"2009-07-13","ids":{"openalex":"https://openalex.org/W2016042652","doi":"https://doi.org/10.1016/j.bmcl.2009.07.058","mag":"2016042652","pmid":"https://pubmed.ncbi.nlm.nih.gov/19643608"},"language":"en","primary_location":{"id":"doi:10.1016/j.bmcl.2009.07.058","doi":"https://doi.org/10.1016/j.bmcl.2009.07.058","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2009.07.058","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic &amp; Medicinal Chemistry Letters","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Ramesh C. Gupta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137505","display_name":"Torrent Pharma (India)","ror":"https://ror.org/03jzw9k83","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210137505"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Ramesh C. Gupta","raw_affiliation_strings":["Medicinal Chemistry, Torrent Research Centre, Torrent Pharmaceuticals Ltd., Gandhinagar, Gujarat, India. rameshgupta@torrentpharma.com","Medicinal Chemistry, Torrent Research Centre, Torrent Pharmaceuticals Ltd, PO Bhat, Gandhinagar 382428, Gujarat, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry, Torrent Research Centre, Torrent Pharmaceuticals Ltd., Gandhinagar, Gujarat, India. rameshgupta@torrentpharma.com","institution_ids":["https://openalex.org/I4210137505"]},{"raw_affiliation_string":"Medicinal Chemistry, Torrent Research Centre, Torrent Pharmaceuticals Ltd, PO Bhat, Gandhinagar 382428, Gujarat, India","institution_ids":["https://openalex.org/I4210137505"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032171315","display_name":"Laxmikant Chhipa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137505","display_name":"Torrent Pharma (India)","ror":"https://ror.org/03jzw9k83","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210137505"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Laxmikant Chhipa","raw_affiliation_strings":["Medicinal Chemistry, Torrent Research Centre, Torrent Pharmaceuticals Ltd, PO Bhat, Gandhinagar 382428, Gujarat, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry, Torrent Research Centre, Torrent Pharmaceuticals Ltd, PO Bhat, Gandhinagar 382428, Gujarat, India","institution_ids":["https://openalex.org/I4210137505"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025338613","display_name":"Appaji Baburao Mandhare","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137505","display_name":"Torrent Pharma (India)","ror":"https://ror.org/03jzw9k83","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210137505"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Appaji B. Mandhare","raw_affiliation_strings":["Medicinal Chemistry, Torrent Research Centre, Torrent Pharmaceuticals Ltd, PO Bhat, Gandhinagar 382428, Gujarat, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry, Torrent Research Centre, Torrent Pharmaceuticals Ltd, PO Bhat, Gandhinagar 382428, Gujarat, India","institution_ids":["https://openalex.org/I4210137505"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101514087","display_name":"Shitalkumar P. Zambad","orcid":"https://orcid.org/0000-0002-4085-8613","observed_orcids":["https://orcid.org/0000-0002-4085-8613"]},"institutions":[{"id":"https://openalex.org/I4210137505","display_name":"Torrent Pharma (India)","ror":"https://ror.org/03jzw9k83","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210137505"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Shitalkumar P. Zambad","raw_affiliation_strings":["Pharmacology, Torrent Research Centre, Torrent Pharmaceuticals Ltd, PO Bhat, Gandhinagar 382428, Gujarat, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology, Torrent Research Centre, Torrent Pharmaceuticals Ltd, PO Bhat, Gandhinagar 382428, Gujarat, India","institution_ids":["https://openalex.org/I4210137505"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027906019","display_name":"Vijay M. Chauthaiwale","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137505","display_name":"Torrent Pharma (India)","ror":"https://ror.org/03jzw9k83","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210137505"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Vijay Chauthaiwale","raw_affiliation_strings":["Discovery Research, Torrent Research Centre, Torrent Pharmaceuticals Ltd, PO Bhat, Gandhinagar 382428, Gujarat, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Research, Torrent Research Centre, Torrent Pharmaceuticals Ltd, PO Bhat, Gandhinagar 382428, Gujarat, India","institution_ids":["https://openalex.org/I4210137505"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049133236","display_name":"Sunil S. Nadkarni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137505","display_name":"Torrent Pharma (India)","ror":"https://ror.org/03jzw9k83","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210137505"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Sunil S. Nadkarni","raw_affiliation_strings":["Torrent Research Centre, Torrent Pharmaceuticals Ltd, PO Bhat, Gandhinagar 382428, Gujarat, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Torrent Research Centre, Torrent Pharmaceuticals Ltd, PO Bhat, Gandhinagar 382428, Gujarat, India","institution_ids":["https://openalex.org/I4210137505"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052279654","display_name":"Chaitanya Dutt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137505","display_name":"Torrent Pharma (India)","ror":"https://ror.org/03jzw9k83","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210137505"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Chaitanya Dutt","raw_affiliation_strings":["Torrent Research Centre, Torrent Pharmaceuticals Ltd, PO Bhat, Gandhinagar 382428, Gujarat, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Torrent Research Centre, Torrent Pharmaceuticals Ltd, PO Bhat, Gandhinagar 382428, Gujarat, India","institution_ids":["https://openalex.org/I4210137505"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210137505"],"apc_list":{"value":3880,"currency":"USD","value_usd":3880},"apc_paid":null,"fwci":0.3954,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.67745941,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"19","issue":"17","first_page":"5021","last_page":"5025"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.5009999871253967,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.5009999871253967,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11140","display_name":"Natural Antidiabetic Agents Studies","score":0.2865999937057495,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12505","display_name":"Peptidase Inhibition and Analysis","score":0.08990000188350677,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9700000286102295},{"id":"https://openalex.org/keywords/dpp-4-inhibition","display_name":"DPP-4 inhibition","score":0.703000009059906},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.9509999752044678},{"id":"https://openalex.org/keywords/insulin-secretion","display_name":"insulin secretion","score":0.7590000033378601},{"id":"https://openalex.org/keywords/glucose-tolerance","display_name":"glucose tolerance","score":0.9869999885559082},{"id":"https://openalex.org/keywords/streptozotocin-induced-diabetes","display_name":"streptozotocin-induced diabetes","score":0.8550000190734863},{"id":"https://openalex.org/keywords/zucker-diabetic-fatty-rats","display_name":"Zucker diabetic fatty rats","score":0.906000018119812},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.8040000200271606}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8776683807373047},{"id":"https://openalex.org/C2781462491","wikidata":"https://www.wikidata.org/wiki/Q410234","display_name":"Piperidine","level":2,"score":0.8763139247894287},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.638877272605896},{"id":"https://openalex.org/C156490143","wikidata":"https://www.wikidata.org/wiki/Q412214","display_name":"Dipeptidyl peptidase-4","level":4,"score":0.5641592144966125},{"id":"https://openalex.org/C2781469919","wikidata":"https://www.wikidata.org/wiki/Q5279728","display_name":"Dipeptidyl peptidase","level":3,"score":0.5465843081474304},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4461560547351837},{"id":"https://openalex.org/C2780282729","wikidata":"https://www.wikidata.org/wiki/Q3121121","display_name":"Saxagliptin","level":5,"score":0.43271899223327637},{"id":"https://openalex.org/C111771559","wikidata":"https://www.wikidata.org/wiki/Q66295","display_name":"Derivative (finance)","level":2,"score":0.41868436336517334},{"id":"https://openalex.org/C114373084","wikidata":"https://www.wikidata.org/wiki/Q273499","display_name":"Chemical synthesis","level":3,"score":0.41247260570526123},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.39984896779060364},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.33084332942962646},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3122295141220093},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.29693669080734253},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.26719021797180176},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.24308207631111145},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.21662494540214539},{"id":"https://openalex.org/C2779284873","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin","level":4,"score":0.09408026933670044},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.05310028791427612},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C106159729","wikidata":"https://www.wikidata.org/wiki/Q2294553","display_name":"Financial economics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006834","descriptor_name":"Hydrazines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D006834","descriptor_name":"Hydrazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006834","descriptor_name":"Hydrazines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011924","descriptor_name":"Rats, Zucker","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018819","descriptor_name":"Dipeptidyl Peptidase 4","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.bmcl.2009.07.058","doi":"https://doi.org/10.1016/j.bmcl.2009.07.058","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2009.07.058","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic &amp; Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmid:19643608","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19643608","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & medicinal chemistry letters","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W1599202069","https://openalex.org/W1965799612","https://openalex.org/W1973351394","https://openalex.org/W1991565451","https://openalex.org/W1995006320","https://openalex.org/W2010922747","https://openalex.org/W2012437459","https://openalex.org/W2042845313","https://openalex.org/W2064780710","https://openalex.org/W2083473802","https://openalex.org/W2161075296","https://openalex.org/W2727473299"],"related_works":["https://openalex.org/W2052515847","https://openalex.org/W2089089552","https://openalex.org/W1975767684","https://openalex.org/W4236561597","https://openalex.org/W3165341325","https://openalex.org/W7161150518","https://openalex.org/W2030250242","https://openalex.org/W2160895888","https://openalex.org/W1997400930","https://openalex.org/W2024944149"],"abstract_inverted_index":null,"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}
